Charles Schwab
NXTM

Charles Schwab’s NxStage Medical Inc. NXTM Stock Holding History

Charles Schwab’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-363,568
Closed -$10.4M – 3221
2018
Q4 		$10.4M Buy
363,568
+741
+0.2% +$21.1K 0.01% 1435
2018
Q3 		$10.1M Buy
362,827
+11,878
+3% +$334K 0.01% 1628
2018
Q2 		$9.79M Buy
350,949
+28,433
+9% +$762K 0.01% 1623
2018
Q1 		$8.02M Buy
322,516
+15,479
+5% +$377K 0.01% 1653
2017
Q4 		$7.44M Buy
307,037
+12,894
+4% +$340K 0.01% 1677
2017
Q3 		$8.12M Buy
294,143
+14,051
+5% +$375K 0.01% 1581
2017
Q2 		$7.02M Buy
280,092
+2,193
+0.8% +$54.3K 0.01% 1600
2017
Q1 		$7.46M Buy
277,899
+18,189
+7% +$502K 0.01% 1517
2016
Q4 		$6.81M Sell
259,710
-70,074
-21% -$1.73M 0.01% 1536
2016
Q3 		$8.24M Sell
329,784
-130,488
-28% -$3.04M 0.01% 1303
2016
Q2 		$9.98M Buy
460,272
+67,283
+17% +$1.2M 0.01% 1069
2016
Q1 		$5.89M Buy
392,989
+169,976
+76% +$2.85M 0.01% 1413
2015
Q4 		$4.89M Buy
223,013
+21,478
+11% +$400K 0.01% 1534
2015
Q3 		$3.18M Buy
201,535
+12,203
+6% +$196K ﹤0.01% 1770
2015
Q2 		$2.71M Buy
189,332
+5,472
+3% +$92.7K ﹤0.01% 1924
2015
Q1 		$3.18M Buy
183,860
+8,094
+5% +$143K ﹤0.01% 1796
2014
Q4 		$3.15M Buy
175,766
+5,667
+3% +$91.3K ﹤0.01% 1752
2014
Q3 		$2.23M Buy
170,099
+3,471
+2% +$46.7K ﹤0.01% 1906
2014
Q2 		$2.4M Buy
166,628
+7,008
+4% +$91.5K ﹤0.01% 1889
2014
Q1 		$2.03M Buy
159,620
+4,074
+3% +$53.1K ﹤0.01% 1948
2013
Q4 		$1.56M Buy
155,546
+24,211
+18% +$275K ﹤0.01% 2051
2013
Q3 		$1.76M Sell
131,335
-3,154
-2% -$41.4K ﹤0.01% 1923
2013
Q2 		$1.95M Buy
+134,489
New +$1.69M ﹤0.01% 1773

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Charles Schwab's NXTM Position: Q1 2019 in Review

Charles Schwab sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 363,568 shares — an estimated $10.4M sold.

Charles Schwab first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $10.4M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Charles Schwab reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Charles Schwab sold 363,568 NxStage Medical Inc. shares in Q1 2019, an estimated $10.4M.
  • Charles Schwab first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
  • Charles Schwab's NxStage Medical Inc. position peaked at $10.4M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Charles Schwab's 13F filing for Q1 2019, filed 14 May 2019.